Posts Tagged ‘preserved systolic ejection fraction’

October 17th, 2013

Questioning Digoxin Use for Patients with Systolic HF

James Freeman discusses his research group’s evaluation of the contemporary effectiveness and safety of digoxin therapy among adults with newly diagnosed systolic heart failure.

October 22nd, 2012

Selections from Richard Lehman’s Literature Review: October 22nd

This week’s topics include favorable lipid-level trends in U.S. adults, an angiotensin receptor neprilysin inhibitor for patients with HF and preserved systolic ejection fraction, and a long-term safety comparison of the Zotarolimus-eluting and Sirolimus-eluting coronary stents.